0
Article ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Human Health Effects Remediation Sign in to save

Targeted activation of ErbB4 receptor ameliorates neuronal deficits and neuroinflammation in a food-borne polystyrene microplastic exposed mouse model

Journal of Neuroinflammation 2025 13 citations ? Citation count from OpenAlex, updated daily. May differ slightly from the publisher's own count. Score: 68 ? 0–100 AI score estimating relevance to the microplastics field. Papers below 30 are filtered from public browse.
Chong Liu, Chong Liu, Yi Ma, Yan Zhao, Yan Zhao, Ji-Ji Dao, Ji-Ji Dao, Wei Zhang, Ji-Ji Dao, Ji-Ji Dao, Yi Ma, Qian Li, Yi Ma, Jia Huang, Chun Cui, Zhenfeng Li, Yi Ma, Yan‐Qin Shen, Yan Zhao, Chen-Meng Qiao, Chun Cui, Wei‐Jiang Zhao Shuangxi Chen, Li Yu, Yan‐Qin Shen, Wei‐Jiang Zhao

Summary

In mice exposed to polystyrene microplastics through food, researchers found significant brain inflammation and cognitive problems, but activating a specific brain receptor (ErbB4) with a small molecule drug helped reverse these effects. This suggests that microplastic exposure through diet may contribute to brain damage, and points toward possible treatments for microplastic-related neurological harm.

Polymers
Models
Study Type In vitro

The impact of polystyrene microplastics (PS-MPs) on the nervous system has been documented in the literature. Numerous studies have demonstrated that the activation of the epidermal growth factor receptor 4 (ErbB4) is crucial in neuronal injury and regeneration processes. This study investigated the role of targeted activation of ErbB4 receptor through a small molecule agonist, 4-bromo-1-hydroxy-2-naphthoic acid (C11H7BrO3, E4A), in mitigating PS-MPs-induced neuronal injury. The findings revealed that targeted activation of ErbB4 receptor significantly ameliorated cognitive behavioral deficits in mice exposed to PS-MPs. Furthermore, E4A treatment upregulated the expression of dedicator of cytokinesis 3 (DOCK3) and Sirtuin 3 (SIRT3) and mitigated mitochondrial and synaptic dysfunction within the hippocampus of PS-MPs-exposed mice. E4A also diminished the activation of the TLR4-NF-κB-NLRP3 signaling pathway, consequently reducing neuroinflammation. In vitro experiments demonstrated that E4A partially alleviated PS-MPs-induced hippocampal neuronal injury and its effects on microglial inflammation. In conclusion, the findings of this study indicate that targeted activation of ErbB4 receptor may mitigate neuronal damage and subsequent neuroinflammation, thereby alleviating hippocampal neuronal injury induced by PS-MPs exposure and ameliorating cognitive dysfunction. These results offer valuable insights for the development of potential therapeutic strategies.

Sign in to start a discussion.

Share this paper